Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Validation of Obesity Interpreter: A Mobile Application-Based Tool for Children and Adolescents.

Indian pediatrics·2026
Same author

Distinguishing Between SIAD and Cerebral Salt Wasting: Is Dynamic Copeptin Response the Answer?

Indian journal of pediatrics·2026
Same author

Clinical Course and Predictors of Metabolic Dysfunction Associated Steatotic Liver Disease in Obese Children and Adolescents.

Indian pediatrics·2026
Same author

Answer to the letter to the editor of T. Tanaka, et al. concerning "patients on antidepressants are more likely to be discharged to inpatient rehabilitation after lumbar fusion" by J. Dalton, et al. (Eur spine J 2025: doi: 10.1007/s00586-025-08815-y).

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2025
Same author

Hyperglycemic Hyperosmolar State as a First Presentation of Type 1 Diabetes Mellitus.

Indian journal of pediatrics·2025
Same author

Pattern formation in Faraday instability-experimental validation of theoretical models.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2023
Same journal

Erratum to: Immunotherapeutic Approach to Cancer with Cutaneous DNA Vaccination.

Methods in molecular medicine·2015
Same journal

Methods for cancer gene therapy using tumor suppressor genes.

Methods in molecular medicine·2014
Same journal

Suppression of the human carcinoma phenotype by an antioncogene ribozyme.

Methods in molecular medicine·2014
Same journal

Methods for the use of stromal cells for therapeutic gene therapy.

Methods in molecular medicine·2014
Same journal

Methods for adenovirus-mediated gene transfer to synovium in vivo.

Methods in molecular medicine·2014
Same journal

Methods for gene transfer to synovium.

Methods in molecular medicine·2014
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Antisense rel A in Cancer.

J R Perez1, K A Higgins-Sochaski, J Y Maltese

  • 1Division of Oncology, Roche Research Center, Hoffmann-La Roche, Nutley, NJ.

Methods in Molecular Medicine
|March 2, 2011
PubMed
Summary
This summary is machine-generated.

Nuclear Factor kappa B (NF-κB) is a transcription factor regulating cellular and viral genes. Upon activation, it translocates to the nucleus to control gene transcription.

More Related Videos

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Genetics

Background:

  • Nuclear Factor kappa B (NF-κB) is a pleiotropic transcription factor involved in regulating cellular and viral genes.
  • The active NF-κB complex is a heterodimer of p65 (rel A) and p50 (NFKB1) subunits, belonging to the rel family of transcription factors.
  • NF-κB is held inactive in the cytoplasm by the inhibitor of NF-κB (IκB) subunit.

Purpose of the Study:

  • To elucidate the mechanism of NF-κB activation and its role in gene regulation.
  • To describe the structural components and activation pathway of the NF-κB transcription factor.

Main Methods:

  • Review of existing literature and experimental findings on NF-κB.
  • Analysis of the protein subunits (p65/rel A, p50/NFKB1) and their interactions.
  • Description of the regulatory role of IκB and its dissociation mechanism.

Main Results:

  • NF-κB activation involves the dissociation of IκB from the NF-κB heterodimer.
  • This dissociation is triggered by stimuli leading to IκB phosphorylation and/or proteolysis.
  • The active NF-κB complex translocates to the nucleus to bind DNA and modulate target gene transcription.

Conclusions:

  • NF-κB plays a critical role in gene expression, with its activity tightly regulated by IκB.
  • The phosphorylation and proteolysis of IκB are key events in NF-κB pathway activation.
  • NF-κB is involved in autoregulatory loops controlling IκB and NFKB1 gene transcription.